6408
Y. Tang et al. / Tetrahedron Letters 49 (2008) 6404–6409
TM
being filtered through a small pad of Celite . The filtrate was concentrated and
the crude bromo-propargyl alcohol was used for the next step without further
purification.
of DCC (1.5 equiv), in CH2Cl2 (0.6 M) at 0 °C. After which, the reaction
mixture was allowed to warm to rt and was stirred overnight being filtered
TM
through a small pad of Celite . The filtrate was concentrated under reduced
Alkynyl chlorides: To solution of respective propargyl alcohol (1.0 equiv) in THF
(0.2 M) was added n-BuLi (1.6 M in hexane) (2.2 equiv) at ꢀ78 °C, and after
10 min, NCS (2.2 equiv) was added into the mixture. The reaction mixture was
stirred at ꢀ78 °C for 1 h, and the ice bath was removed to allow the mixture to
warm up to rt. After which, the reaction mixture was stirred at r.t. for 10 min.
The mixture was then diluted with H2O (20 mL) and extracted with CH2Cl2
(150 mL). The organic layer was dried (MgSO4). The solution was distilled
under reduced pressure. The crude chloro-propargyl alcohol was used for the
next step without further purification.
Rearrangement: To a solution of an alkynyl halide, the preparation of which is
described above, in anhyd toluene (0.2 M) were added triethyl orthoacetate
(2.0 equiv) and acetic acid (5 mol %), and the reaction mixture was heated for
18 h at 100 °C in a sealed tube. The solvent was removed under reduced
pressure, and the crude residue was purified using flash silica gel column
chromatography (gradient eluent: 0–10% ether in pentane) to provide allenyl
bromide as yellow oil. For characterizations, see: Compound 11-P: (56.8 mg,
pressure, and the crude residue was purified using flash silica gel column
chromatography (gradient eluent: 0–10% EtOAc in hexanes) to provide the
corresponding ester.
For selected characterizations, see: Compound 18-P: (9.10 mg, 44% yield).
Rf = 0.57 (50% EtOAc in hexanes); ½a D20
ꢀ4.40 (c 3.15 in CH2Cl2); ‘&’ indicates
ꢁ
rotamers. 1H NMR (500 MHz, CDCl3) d 1.76 (t, 3H, J = 7.5 Hz), 1.90–2.02 (m,
3H), 2.19–2.02 (m, 1H), 2.56–2.59 (m, 1H), 2.70–2.74 (m, 1H), 3.46–3.56 (m,
1H), 3.59–3.65 (m, 1H), 4.01–4.16 (m, 1H), 4.23–4.31 (m, 1H), 4.36 & 4.40
(dd, 1H, J = 4.0, 9.0 Hz), 5.07–5.19 (m, 2 H), 6.26–5.33 (m, 1H), 7.29–7.37 (m,
5H); IR (thin film) cmꢀ1 2953w, 1698s, 1417m, 1350w, 1166m, 1116w,
1058w; mass spectrum (ESI): m/e (% relative intensity) 430.5 (100) (M+Na)+,
432.5 (98) (M+2+Na)+. Compound 18-M: (8.50 mg, 42% yield). Rf = 0.57 (50%
EtOAc in hexanes); ½a D20
ꢁ
ꢀ 63.0 (c 8.65 in CH2Cl2); ‘&’ indicates rotamers. 1H
NMR (500 MHz, Toluene-d8) d 1.38 (dd, 3H, J = 7.5, 33.0 Hz), 1.46–1.62 (m,
3H), 2.05–2.10 (m, 1H), 2.26–2.10 (m, 1H), 2.41–2.44 (m, 1H), 3.05–3.07 &
3.23–3.28 (m, 1H), 3.32–3.37 & 3.45–3.52 (m, 1H), 3.94 (t, 1H, J = 6.0 Hz),
4.04 (t, 1H, J = 6.0 Hz), 4.08–4.11 & 4.27–4.30 (m, 1H), 4.92–5.14 (m, 3H),
6.98–7.19 (m, 5H); IR (thin film) cmꢀ1 2955m, 1698s, 1417m, 1350m, 1167s,
1116w, 1085; mass spectrum (ESI): m/e (% relative intensity) 430.5 (100)
(M+Na)+, 432.5 (98) (M+2+Na)+.
55% yield). Rf = 0.57 (25% EtOAc in hexanes); ½a D20
ꢁ
82.0 (c 0.64 in CH2Cl2); 1H
NMR (400 MHz, CDCl3) d 1.27 (t, 3H, J = 7.2 Hz), 1.77 (d, 3H, J = 7.2 Hz), 3.41 (d,
2H, J = 2.0 Hz), 4.18 (q, 2H, J = 7.2 Hz), 5.33 (qt, 1H, J = 7.2, 2.4 Hz); 13C NMR
(100 MHz, CDCl3) d 14.2, 14.3, 43.9, 61.3, 83.3, 94.6, 169.2, 202.1; IR (thin
film) cmꢀ1 2981w, 1734s, 1156w, 1033w; mass spectrum (ESI): m/e (% relative
intensity) 241.2 (100) (M+Na)+, 243.2 (83) (M+2+Na)+. Compound 11-M:
Compound 21-P: (19.0 mg, 80% yield). Rf = 0.10 (20% EtOAc in hexanes); ½a D20
ꢁ
38.0 (c 0.56 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 0.88 (t, 3H,J = 7.0 Hz),
1.20–1.39 (m, 6H), 1.57 (d, 3H,J = 7.5 Hz), 1.97 (dt, 2H, J = 7.5, 14.0 Hz), 2.56–
2.65 (m, 2H), 3.85 (q, 1H,J = 8.0 Hz), 3.91 (s, 3H), 4.17–4.28 (m, 2H), 5.32–
5.37 (m, 1H), 7.10–7.16 (m, 2H), 7.38–7.42 (m, 1H), 7.65–7.72 (m, 3H); 13C
NMR (125 MHz, CDCl3) d 14.3, 18.9, 22.7, 28.3, 29.3, 31.4, 36.0, 45.7, 55.6,
62.0, 101.2, 101.4, 105.8, 119.2, 126.2, 126.5, 127.4, 129.2, 129.5, 134.0,
135.8, 157.9, 174.7, 199.7; IR (thin film) cmꢀ1 2928w, 1734s, 1154m, 1032w;
mass spectrum (ESI): m/e (% relative intensity) 423.6 (100) (M+Na)+, 425.6
(29) (M+2+Na)+. Compound 21-M: (24.0 mg, 83% yield). Rf = 0.10 (20% EtOAc
(51.2 mg, 51% yield). Rf = 0.57 (25% EtOAc in hexanes); ½a D20
ꢀ83.0 (c 0.53 in
ꢁ
CH2Cl2); 1H NMR (500 MHz, CDCl3) d1.26 (t, 3H, J = 7.5 Hz), 1.78 (d, 3H,
J = 7.0 Hz), 3.41 (d, 2H, J = 2.0 Hz), 4.17 (q, 2 H, J = 7.5 Hz), 5.33 (qt, 1H, J = 7.5,
2.5 Hz); 13C NMR (125 MHz, CDCl3) d 14.2, 14.6, 44.1, 61.5, 83.3, 94.7, 169.3,
202.1; IR (thin film) cmꢀ1 2981w, 1939s, 1167s, 1032w; mass spectrum (ESI):
m/e (% relative intensity) 241.2 (100) (M+Na)+, 243.2 (83) (M+2+Na)+.
Compound 14-P: (22.1 mg, 40% yield). Rf = 0.68 (33% EtOAc in hexanes); ½a D20
ꢁ
85.0 (c 0.43 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 1.28 (t, 3 H, J = 7.5 Hz),
3.57 (dq, 2H, J = 2.0, 16.5 Hz), 4.21 (q, 2H, J = 7.0 Hz), 6.29 (t, 1H, J = 2.0 Hz),
7.25–7.41 (m, 5H); 13C NMR (125 MHz, CDCl3) d 14.4, 44.1, 61.7, 86.6, 101.4,
128.4, 128.9, 129.1, 132.3, 169.0, 202.4; IR (thin film) cmꢀ1 2981w, 1734s,
1235m, 1178s, 1027m; mass spectrum (ESI): m/e (% relative intensity) 303.3
(75) (M+Na)+, 305.3 (72) (M+2+Na)+. 14-M: (24.3 mg, 42% yield). Rf = 0.68 (33%
in hexanes); ½a 2D0
ꢁ
ꢀ1.50 (c 0.55 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 0.88
(t, 3H, J = 7.5 Hz), 1.20–1.34 (m, 6H), 1.29–1.31 (m, 2H), 1.57 (d, 3H,
J = 7.5 Hz), 1.93 (q, 2H, J = 7.0 Hz), 2.60 (dt, 2H,J = 2.5, 6.5 Hz), 3.85 (q, 1H,
J = 7.5 Hz), 3.92 (s, 3H), 4.17–4.27 (m, 2H), 5.23–5.29 (m, 1H), 7.10–7.16 (m,
2H), 7.39–7.42 (m, 1H), 7.65–7.73 (m, 3H); 13C NMR (125 MHz, CDCl3) d 14.3,
18.8, 22.7, 28.3, 29.3, 31.4, 36.0, 45.7, 55.6, 62.0, 101.2, 101.4 105.8, 119.3,
126.2, 126.5, 127.4, 129.2, 129.5, 134.0, 135.9, 157.9, 174.7, 199.6; IR (thin
film) cmꢀ1 2930w, 1733s, 1233w, 1174w, 1033w; mass spectrum (ESI): m/e
(% relative intensity) 423.6 (100) (M+Na)+, 425.6 (29) (M+2+Na)+.
EtOAc in hexanes); ½a D20
ꢁ
ꢀ123.0 (c 0.63 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d
1.28 (t, 3 H, J = 7.5 Hz), 3.56 (dq, 2H, J = 2.5, 16.5 Hz), 4.21 (q, 2H, J = 7.5 Hz),
6.29 (t, 1H, J = 2.0 Hz), 7.26–7.41 (m, 5H); 13C NMR (125 MHz, CDCl3) d 14.4,
44.1, 61.7, 86.6, 101.4, 128.4, 128.9, 129.1, 132.3, 169.0, 202.4; IR (thin
film) cmꢀ1 1737s, 1220s, 1014m; mass spectrum (ESI): m/e (% relative
intensity) 303.3 (100) (M+Na)+; 305.3 (100) (M+2+Na)+.
General Procedure for addition of allenyl bromides 11-P to benzaldehyde: To a
stirred solution of allenyl bromide 11-P (1.0 equiv) in THF (0.5 M) were
added CuCl (0.10 equiv), HSiCl3 (2.0 equiv), and iPr2NEt (2.0 equiv)
successively at rt. The mixture was stirred at 40 °C for 6 h. After which,
DMF-CH3CN (0.5 M, 1:1 v/v) was added and the mixture was cooled to 0 °C.
Then benzaldehyde (1.0 equiv) was added, and the mixture was kept at 0 °C
for 18 h before being quenched with cold H2O and extracted with ether. The
extract was washed with sat aq NaCl, dried over Na2SO4, and concentrated
under reduced pressure. The crude residue was purified using flash silica gel
column chromatography (gradient eluent: 0–50% EtOAc in hexanes) to
provide the allenylic alcohol. For characterizations, see: Compound 22-[P,S]:
Compound 16-P: (28.7 mg, 52% yield). Rf = 0.67 (33% EtOAc in hexanes); ½a D20
ꢁ
127.0 (c 0.96 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 0.89–0.92 (m, 3H), 1.26–
1.33 (m, 7 H), 1.46–1.48 (m, 2 H), 2.13 (dq, 2H, J = 3.0, 7.5 Hz), 3.44 (d, 2H,
J = 2.5 Hz), 4.20 (q, 2H, J = 7.0 Hz), 5.37–5.42 (m, 1H); 13C NMR (125 MHz,
CDCl3) d 14.0, 14.1, 22.3, 27.8, 28.4, 31.1, 43.9, 61.1, 83.7, 99.6, 168.9, 201.0; IR
(thin film) cmꢀ1 2928m, 1735s, 1157m, 1032m; mass spectrum (ESI): m/e (%
relative intensity) 297.3 (100) (M+Na)+, 299.3 (99) (M+2+Na)+. Compound 16-
M: (24.9 mg, 48% yield). Rf = 0.67 (33% EtOAc in hexanes); ½a D20
ꢀ106.0 (c 0.81
ꢁ
in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 0.81–0.91 (m, 3H), 1.20–1.29 (m, 7H),
1.36–1.44 (m, 2H), 2.06 (dq, 2H, J = 3.0, 7.5 Hz), 3.36 (s, 2H), 4.13 (q, 2H,
J = 7.5 Hz), 5.31–5.35 (m, 1H); 13C NMR (125 MHz, CDCl3) d 14.0, 14.1, 22.4,
27.8, 28.4, 31.1, 43.9, 61.1, 83.8, 99.6, 168.8, 201.1; IR (thin film) cmꢀ1 2927 m,
1734s, 1156m, 1031m; mass spectrum (ESI): m/e (% relative intensity) 297
(100) (M+Na)+, 299.3 (98) (M+2+Na)+.
(7.10 mg, 57% yield). Rf = 0.23 (20% EtOAc in hexanes); ½a D20
ꢀ21.0 (c 1.05 in
ꢁ
CH2Cl2); 1H NMR(400 MHz, CDCl3)
d 1.23 (t, 3H, J = 7.2 Hz), 1.69 (d, 3H,
J = 7.2 Hz), 2.91 (dq, 2H, J = 2.0, 16.4 Hz), 3.20–3.22 (m, 1H), 4.10 (q, 2H,
J = 7.2 Hz), 5.28–5.30 (m, 1H), 5.31–5.37 (m, 1H), 7.24–7.39 (m, 5H); 13C NMR
(100 MHz, CDCl3) d 14.4, 14.5, 35.5, 61.3, 74.6, 90.0, 101.2, 126.6, 127.8,
128.4, 142.1, 172.7, 203.4; IR (thin film) cmꢀ1 2981w, 1733m, 1716s, 1156m,
1025m; mass spectrum (MALDI): m/e (% relative intensity) 269 (100)
(M+Na)+; m/e calcd for C15H18O3Na+269.1148, found 269.1152. 22-[M,R]:
Compound 17-P: (25.5 mg, 46% yield). Rf = 0.65 (10% MTBE in hexanes); ½a D20
ꢁ
20.9 (c 2.5 in CH2Cl2); 1H NMR (500 MHz, CDCl3) d 0.88–0.91 (m, 3H), 1.23–
1.36 (m, 7H), 1.42–1.50 (m, 2H), 2.11 (q, 2H, J = 7.5 Hz), 3.32 (d, 2H, J = 2.0 Hz),
4.19 (q, 2H, J = 7.2 Hz), 5.60–5.63 (m, 1H); 13C NMR (125 MHz, CDCl3) d 14.3,
14.4, 22.7, 28.1, 29.2, 31.4, 42.9, 61.4, 98.3, 101.2, 169.2, 201.0; IR (thin
film) cmꢀ1 2929m, 2369s, 1734m, 1158w; mass spectrum (ESI): m/e (% relative
intensity) 253.4 (90) (M+Na)+. Compound 17-M: (9.3 mg, 46% yield). Rf = 0.65
(4.40 mg, 51% yield). Rf = 0.23 (20% EtOAc in hexanes); ½a D20
ꢁ
18.8 (c 1.85 in
CH2Cl2); 1H NMR (400 MHz, CDCl3) d 1.23 (t, 3H, J = 6.8 Hz), 1.69 (d, 3H,
J = 6.8 Hz), 2.91 (dq, 2H, J = 2.0, 16.4 Hz), 3.18–3.22 (m, 1H), 4.11 (q, 2H,
J = 7.2 Hz), 5.28–5.30 (m, 1H), 5.31–5.40 (m, 1H), 7.24–7.39 (m, 5H); 13C NMR
(100 MHz, CDCl3) d 14.4, 14.5, 35.5, 61.3, 74.6, 90.0, 101.2, 126.6, 127.8,
128.4, 142.1, 172.7, 203.4; IR (thin film) cmꢀ1 2982w, 1733m, 1716m, 1157w,
1025m; mass spectrum (MALDI): m/e (% relative intensity) 269 (100)
(M+Na)+; m/e Calcd for C15H18O3Na+ 269.1148, found 269.1148.
21. For leading references on such asymmetric reductions, see: (a) Bach, J.;
Berenguer, R.; Garcia, J.; Loscertales, T.; Vilarrasa, J. J. Org. Chem. 1996,
61, 9021; (b) Helal, C. J.; Magriotis, P. A.; Corey, E. J. J. Am. Chem. Soc. 1996, 118,
10938; (c) Matsumura, K.; Hashiguchi, S.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc.
1997, 119, 8738; (d) Parker, K. A.; Ledeboer, M. W. J. Org. Chem. 1996, 61,
3214.
(10% MTBE in hexanes); ½a D20
ꢁ
ꢀ18.5 (c 1.90 in CH2Cl2); 1H NMR (500 MHz,
CDCl3) d 0.88–0.92 (m, 3H), 1.25–1.40 (m, 7H), 1.42–1.50 (m, 2H), 2.12 (q, 2H,
J = 7.2 Hz), 3.33 (d, 2H, J = 1.8 Hz), 4.20 (q, 2H, J = 6.9 Hz), 5.59–5.67 (m, 1H);
13C NMR (125 MHz, CDCl3) d 14.0, 14.1, 22.4, 27.8, 28.9, 31.2, 42.6, 61.2, 98.0,
100.9, 168.9, 200.8; IR (thin film) cmꢀ1 2929m, 2364s, 1734m, 1158w; mass
spectrum (ESI): m/e (% relative intensity) 253.4 (18) (M+Na)+.
General procedure of DIBAL-H reduction and esterification: A solution of the
respective allenyl bromide (or chloride) in toluene (0.2 M) was cooled to 0 °C
followed by the addition of DIBAL-H (2.2 equiv). The reaction mixture was
stirred for 2 h at 0 °C before it was quenched with MeOH and diluted with
EtOAc. A sat aq K/Na–tartrate solution was then added, and the mixture was
stirred for another 2–4 h until it was separated as two clear layers. The
aqueous layer was extracted twice with EtOAc (equal volume) after separation.
The combined organic extracts were concentrated under reduced pressure,
and the crude alcohol was used for the next step without further purification.
22. For reviews on asymmetric additions of acetylenes to carbonyl systems, see:
(a) Pu, L.; Yu, H.-B. Chem. Rev. 2001, 101, 757; (b) Pu, L. Tetrahedron 2003, 59,
9873; (c) Walsh, P. J. Acc. Chem. Res. 2003, 36, 739.
23. For a review, see: (a) Marshall, J. A.; Gung, B. W.; Grachan, M. L. In Modern
Allene Chemistry; Krause, N., Hashmi, A. S. K., Eds.; Wiley-VCH Verlag GmbH &
Co. KGaA: Weinheim, 2004; Vol. 1, pp 493–592; (b) Marshall, J. A. Chem. Rev.
1996, 96, 31.
To
a solution of the above mentioned crude alcohol, carboxylic acid
(1.5 equiv), and DMAP (0.1 equiv) in CH2Cl2 (0.2 M) was added a solution